GIGYF2 is present in endosomal compartments in the mammalian brains and enhances IGF‐1‐induced ERK1/2 activation
Open Access
- 28 July 2010
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 115 (2), 423-437
- https://doi.org/10.1111/j.1471-4159.2010.06930.x
Abstract
J. Neurochem. (2010) 115, 423–437. Abstract GIGYF2 has been reported as a candidate gene for PARK11-linked Parkinson’s disease (PD). Heterozygous knockout of GIGYF2 results in neurodegeneration, suggesting important roles for GIGYF2 (Grb10 interacting GYF protein 2) in the CNS. In this study, we used novel GIGYF2 antibodies to clarify the distribution and function of GIGYF2. GIGYF2 was widely expressed, most highly in the pancreas and testis, and moderately in brain, lung, liver, kidney and spleen. In the brain, GIGYF2 was tightly associated with membrane in the S3 fraction, and localised in neuronal perikarya and proximal dendrites. Immunohistochemical analysis indicated sites of GIGYF2 localisation throughout the mouse brain, with high levels in the cerebral cortex, hippocampus, cerebellum, olfactory bulb and brainstem nuclei, but low levels in the substantia nigra and striatum. GIGYF2 was present in endosomes immunopositive for Rab4 and Grb10. Expression of GIGYF2 altered insulin-like growth factor-1 (IGF-1) receptor trafficking and enhanced IGF-1-induced extracellular signal-regulated kinase 1/2 phosphorylation, but not IGF-1 receptor or serine/threonine protein kinase Akt phosphorylation. There were no significant differences in signalling activation between cells expressing wild-type and putative PD-associated mutant GIGYF2. In PD brains, GIGYF2 did not localise to Lewy bodies. Our findings indicate a role for GIGYF2 in the regulation of signalling at endosomes, but no contribution of GIGYF2 to the pathogenesis of PD.Keywords
This publication has 49 references indexed in Scilit:
- Familial amyotrophic lateral sclerosis-linked mutant SOD1 aberrantly interacts with tubulinBiochemical and Biophysical Research Communications, 2009
- GIGYF2 gene disruption in mice results in neurodegeneration and altered insulin-like growth factor signalingHuman Molecular Genetics, 2009
- Abnormal Localization of Leucine-Rich Repeat Kinase 2 to the Endosomal-Lysosomal Compartment in Lewy Body DiseaseJournal of Neuropathology and Experimental Neurology, 2009
- Variation in GIGYF2 is not associated with Parkinson diseaseNeurology, 2009
- Membrane-associated farnesylated UCH-L1 promotes α-synuclein neurotoxicity and is a therapeutic target for Parkinson's diseaseProceedings of the National Academy of Sciences of the United States of America, 2009
- Lack of replication of association between GIGYF2 variants and Parkinson diseaseHuman Molecular Genetics, 2008
- Aberrant Interaction between Parkinson Disease-associated Mutant UCH-L1 and the Lysosomal Receptor for Chaperone-mediated AutophagyOnline Journal of Public Health Informatics, 2008
- Mutations in the GIGYF2 (TNRC15) Gene at the PARK11 Locus in Familial Parkinson DiseaseAmerican Journal of Human Genetics, 2008
- Functionally significant insulin-like growth factor I receptor mutations in centenariansProceedings of the National Academy of Sciences of the United States of America, 2008
- Localization of Parkinson’s disease-associated LRRK2 in normal and pathological human brainBrain Research, 2007